As of April 2024 Sorrento Therapeutics has a market cap of $16.53 Million. This makes Sorrento Therapeutics the world's 8029th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $16.53 M | -75.71% |
2023 | $68.08 M | -83.72% |
2022 | $0.41 B | -71.42% |
2021 | $1.46 B | -22.14% |
2020 | $1.87 B | 231.27% |
2019 | $0.56 B | 93.26% |
2018 | $0.29 B | -6.61% |
2017 | $0.31 B | 10.68% |
2016 | $0.28 B | -13.7% |
2015 | $0.32 B | -9.71% |
2014 | $0.36 B | 95.35% |
2013 | $0.18 B | 314.34% |
2012 | $45.01 M | -9.9% |
2011 | $49.96 M | -66.8% |
2010 | $0.15 B | -65.18% |
2009 | $0.43 B | 8572.25% |
2008 | $4.98 M | -58.11% |
2007 | $11.89 M |
On Apr 26th, 2024 the market cap of Sorrento Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Karyopharm Therapeutics
KPTI | $0.12 B | 646.47% | ๐บ๐ธ USA |
Exelixis EXEL | $6.98 B | 42,145.61% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | $2.97 B | 17,904.74% | ๐บ๐ธ USA |